Welcure Drugs & Pharmaceuticals Ltd.
|
QUARTERLY RESULTS
|
|
You can view the
Quaterly Results
for the last 5 years.
Market Cap. (Rs.)
|
109.32 Cr.
|
P/BV
|
1.07
|
Book Value (Rs.)
|
9.12
|
52 Week High/Low (Rs.)
|
16/6
|
FV/ML
|
10/1
|
P/E(X)
|
50.41
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.19
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
Net Sales/Income from operations | 299.91 | 21.21 | 8.84 | 24.55 | 0.00 |
Total Income From Operations | 299.91 | 21.21 | 8.84 | 24.55 | 0.00 |
Purchase of Traded Goods | 268.72 | 147.62 | 0.00 | 164.03 | 0.00 |
Increase/Decrease in Stocks | 0.00 | -129.91 | 7.38 | -143.52 | 0.00 |
Employees Cost | 0.03 | 0.25 | 0.11 | 0.10 | 0.05 |
Depreciation | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
Other Expenses | 0.02 | 2.61 | 0.42 | 2.11 | 0.29 |
Total Expenses | 268.78 | 20.58 | 7.92 | 22.71 | 0.35 |
| | | | | |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 31.14 | 0.63 | 0.91 | 1.84 | -0.35 |
Other Income | 0.00 | 1.91 | 0.00 | 0.00 | 0.00 |
P/L Before Interest, Excpt. Items & Tax | 31.14 | 2.54 | 0.91 | 1.84 | -0.35 |
P/L Before Exceptional Items & Tax | 31.14 | 2.54 | 0.91 | 1.84 | -0.35 |
P/L Before Tax | 31.14 | 2.54 | 0.91 | 1.84 | -0.35 |
Tax | 7.84 | 0.00 | 0.50 | 0.00 | 0.00 |
P/L After Tax from Ordinary Activities | 23.30 | 2.54 | 0.41 | 1.84 | -0.35 |
Net Profit/Loss For the Period | 23.30 | 2.54 | 0.41 | 1.84 | -0.35 |
| | | | | |
Equity Share Capital | 112.36 | 112.44 | 112.44 | 13.44 | 13.44 |
EPS Before Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 2.07 | 0.33 | 0.04 | 0.16 | -0.26 |
Diluted EPS (Rs.) | 2.07 | 0.33 | 0.04 | 0.16 | -0.26 |
EPS After Extra Ordinary * | | | | | |
Basic EPS (Rs.) | 2.07 | 0.33 | 0.04 | 0.16 | -0.26 |
Diluted EPS (Rs.) | 2.07 | 0.33 | 0.04 | 0.16 | -0.26 |
| | | | | |
PBITOE Margin (%) | 10.38 | 2.96 | 10.34 | 7.48 | N.A |
PBTE Margin (%) | 10.38 | 11.97 | 10.34 | 7.48 | N.A |
PBT Margin (%) | 10.38 | 11.97 | 10.34 | 7.48 | N.A |
PAT Margin (%) | 7.76 | 11.97 | 4.68 | 7.48 | N.A |